Skip to main content

Table 1 Selected agonists and antagonists and applied antagonist concentrations for functional MUAS chamber experiments

From: Nanomolar EP4 receptor potency and expression of eicosanoid-related enzymes in normal appearing colonic mucosa from patients with colorectal neoplasia

Receptor subtype

Agonist

Antagonist with concentration

EP1 receptor

ONO-DI004

SC 51322

2 µM

EP2 receptor

ONO-AE1-259

PF 04418948

3 µM

EP3 receptor

Sulprostone

L-798,106

500 nM

EP4 receptor

TCS 2510

L-161,982

2 µM

  

GW627368X

5 µM